Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(1):21-29; doi:10.1093/jnci/dji004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Figure
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Farias, E. F.
Right arrow Articles by Mira y Lopez, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farias, E. F.
Right arrow Articles by Mira y Lopez, R.
Related Collections
Right arrowEditorial about this Article
Right arrowRelated Memo to the Media
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

ARTICLE

Cellular Retinol-Binding Protein I, a Regulator of Breast Epithelial Retinoic Acid Receptor Activity, Cell Differentiation, and Tumorigenicity

Eduardo F. Farias, David E. Ong, Norbert B. Ghyselinck, Shigeo Nakajo, Yuvarani S. Kuppumbatti, Rafael Mira y Lopez

Affiliations of authors: Department of Medicine, Mount Sinai School of Medicine, New York, NY (EFF, YSK, RML); Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN (DEO); I.G.B.M.C., CNRS/INSERM/Université Louis Pasteur, Collège de France, B.P. 10142, 67404, Illkirch Cedex, France (NBG); Laboratory of Biological Chemistry, School of Pharmaceutical Sciences, Showa University, Japan (SN)

Correspondence to: Eduardo F. Farias, PhD, Mount Sinai School of Medicine, Department of Medicine, Annenberg Bldg., Rm 24-74, One Gustave L. Levy Place, New York, NY 10029 (e-mail: eduardo.farias{at}mssm.edu)

Background: Retinoic acid receptor (RAR) activation induces cell differentiation and may antagonize cancer progression. Cellular retinol-binding protein I (CRBP-I) functions in retinol storage and its expression is lower in human cancers than in normal cells. We hypothesized that retinol storage might be linked to RAR activation and thus that lowered CRBP-I function might impair RAR activity and cell differentiation. Methods: Sarcoma virus 40-immortalized human mammary epithelial cells (MTSV1-7) devoid of CRBP-I were transfected with wild-type CRBP-I or CRBP-I point mutants with low RA binding affinity. The subcellular localization of CRBP-I was investigated in these cells and in wild-type or CRBP-I null mouse mammary epithelial cells (MECs), using indirect immunofluorescence and sucrose gradient fractionation. RAR activity was assessed using reporter gene assays. Acinar differentiation and in vivo tumor growth were assessed in reconstituted basement membrane and athymic mice, respectively. Results: In cells expressing wild-type CRBP-I but not the CRBP-I mutants, CRBP-I was found mainly in lipid droplets, the retinol storage organelle, and this localization was associated with promotion of retinol storage by wild-type CRBP-I only. RAR activity was higher and acinar differentiation was observed in cells expressing wild-type but not mutant CRBP-I. RAR antagonist treatment blocked and chronic RA treatment mimicked, the CRBP-I induction of cell differentiation. Finally, CRBP-I suppressed tumorigenicity in athymic mice. Conclusions: Physiologic RAR activation is dependent on CRBP-I-mediated retinol storage, and CRBP-I downregulation chronically compromises RAR activity, leading to loss of cell differentiation and tumor progression.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Editorial about this Article

A Crucial Role for Cellular Retinol-Binding Protein I in Retinoid Signaling
Reuben Lotan
J Natl Cancer Inst 2005 97: 3-4. [Extract] [Full Text] [PDF]

Related Memo to the Media

Press Release: Study Examines Relationship of Vitamin A Pathway to Breast Tumor Progression
Sarah L. Zielinski
J Natl Cancer Inst 2005 97: 1. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
K. Kohlstedt, C. Gershome, C. Trouvain, W.-K. Hofmann, S. Fichtlscherer, and I. Fleming
Angiotensin-Converting Enzyme (ACE) Inhibitors Modulate Cellular Retinol-Binding Protein 1 and Adiponectin Expression in Adipocytes via the ACE-Dependent Signaling Cascade
Mol. Pharmacol., March 1, 2009; 75(3): 685 - 692.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Van Beneden, L. A. van Grunsven, C. Geers, M. Pauwels, A. Desmouliere, D. Verbeelen, A. Geerts, and C. Van den Branden
CRBP-I in the renal tubulointerstitial compartment of healthy rats and rats with renal fibrosis
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3464 - 3471.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Zaitseva, B. J. Vollenhoven, and P. A.W. Rogers
Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium
Mol. Hum. Reprod., August 1, 2007; 13(8): 577 - 585.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Bistulfi, S. Pozzi, M. Ren, S. Rossetti, and N. Sacchi
A Repressive Epigenetic Domino Effect Confers Susceptibility to Breast Epithelial Cell Transformation: Implications for Predicting Breast Cancer Risk
Cancer Res., November 1, 2006; 66(21): 10308 - 10314.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.